Haofeng Medical Completes $14M Pre-B Round Financing to Advance Interventional Medical Device CDMO

Haofeng Medical, a leading Chinese CDMO (Contract Development and Manufacturing Organization) specializing in Class III interventional medical devices, has successfully completed a Pre-B round financing, raising nearly 100 million RMB (approximately $14 million). The round was led by Zhuhai High-Tech Financial Investment and was supported by existing shareholder Cenova Capital. The funds will be used to expand the company’s production capacity, further develop its business, and strengthen its global presence to better meet the diverse needs of international clients.

With strategic R&D and production bases in Shenzhen, Guangdong, and Qidong, Jiangsu, Haofeng Medical operates a comprehensive CDMO platform covering key components such as balloon catheters, interventional catheters, and guidewires. The company has also established several specialized technology development platforms, including those for materials welding, forming, precision assembly, and surface functionality. In addition to its domestic presence, Haofeng has secured strategic partnerships with benchmark clients across Europe, Latin America, and Southeast Asia, positioning itself as a global player in the medical device CDMO sector.

Liu Chunjie, Chairman of Haofeng Medical, commented on the financing, stating, “The growing demand for high-value medical consumables in China, combined with the need for localized supply chains and high-quality products, is driving rapid development in the local medical device industry. With years of experience, Haofeng Medical has built an integrated platform for smart equipment, components, and materials services. We are committed to becoming a lean manufacturing expert in the medical device field, providing efficient and high-quality services across the industry chain.”